{"id":"https://openalex.org/W4403129348","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","title":"T-DM1 in Chinese patients with Her2-positive metastatic breast cancer: A multi-center, retrospective, real world study.","display_name":"T-DM1 in Chinese patients with Her2-positive metastatic breast cancer: A multi-center, retrospective, real world study.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4403129348","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.e13026","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.e13026","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.e13026","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075065460","display_name":"Ruyan Zhang","orcid":"https://orcid.org/0000-0001-9129-0602","observed_orcids":["https://orcid.org/0000-0001-9129-0602","https://orcid.org/0009-0005-1848-8109"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruyan Zhang","raw_affiliation_strings":["Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100605683","display_name":"Huiping Li","orcid":"https://orcid.org/0000-0002-3331-647X","observed_orcids":["https://orcid.org/0000-0002-3331-647X"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huiping Li","raw_affiliation_strings":["Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101567918","display_name":"Pin Zhang","orcid":"https://orcid.org/0000-0002-1357-9539","observed_orcids":["https://orcid.org/0000-0002-1357-9539"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210141458","display_name":"Cancer Hospital of Chinese Academy of Medical Sciences","ror":"https://ror.org/03x937183","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Pin Zhang","raw_affiliation_strings":["National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210141458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112570153","display_name":"Chunfang Hao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunfang Hao","raw_affiliation_strings":["Tianjin Medical University Cancer Institute and Hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Medical University Cancer Institute and Hospital, Tianjin, China","institution_ids":["https://openalex.org/I2802573037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022272629","display_name":"Wenhui Zhao","orcid":"https://orcid.org/0000-0003-2211-2030","observed_orcids":["https://orcid.org/0000-0003-2211-2030"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenhui Zhao","raw_affiliation_strings":["Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090541397","display_name":"Xueli Mo","orcid":"https://orcid.org/0009-0007-5343-0302","observed_orcids":["https://orcid.org/0009-0007-5343-0302"]},"institutions":[{"id":"https://openalex.org/I4210139292","display_name":"Peking University Shougang Hospital","ror":"https://ror.org/040rwep31","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210139292"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xueli Mo","raw_affiliation_strings":["Shougang Beijing University Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shougang Beijing University Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210139292"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/her2-positive-metastatic-breast-cancer","display_name":"HER2-positive metastatic breast cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.8650000095367432},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8619999885559082},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7009999752044678},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8289999961853027},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.8130000233650208},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.7179999947547913},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.6399999856948853},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.746999979019165},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9079999923706055},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.722000002861023},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.5839999914169312},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.3490000069141388}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9128324389457703},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6581295728683472},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6411119103431702},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5490669012069702},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5055902004241943},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.5049596428871155},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47618308663368225},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4307515025138855},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3431040048599243},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.e13026","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.e13026","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.e13026","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13026","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.e13026","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4403129348.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2594642846","https://openalex.org/W2137754029","https://openalex.org/W2793230682","https://openalex.org/W4220694649","https://openalex.org/W4391288080","https://openalex.org/W2971837858","https://openalex.org/W2769782591","https://openalex.org/W2662154495","https://openalex.org/W4396228092","https://openalex.org/W2588389315"],"abstract_inverted_index":{"e13026":[0],"Background:":[1],"In":[2,291],"the":[3,9,15,33,114,230,249,302,314,322,341,356],"pivotal":[4],"EMILIA":[5,323],"and":[6,29,58,66,79,94,116,144,151,155,162,184,206,219,240,260,273,307,325,345,350,369],"THRESA":[7],"study,":[8,295],"proportion":[10],"of":[11,22,99,109,130,169,180,232,275,301,336,343,367],"Chinese":[12],"patients":[13,26,31,43,101,136,146,157,182,233,271,279,282,303,346,371],"in":[14,27,32,52,61,113,139,149,178,222,296],"clinical":[16],"trials":[17,34],"was":[18,74,122,133,192,199,204,208,251,317,363],"very":[19],"low":[20],"(17%":[21],"Asian":[23],"patients,":[24],"87":[25],"EMILIA),":[28],"no":[30],"were":[35,111,137,147,224,257,268],"previously":[36,159],"treated":[37,138,148],"with":[38,44,226,234,321,347],"pertuzumab.":[39],"Methods:":[40],"We":[41],"enrolled":[42],"Her2-positive":[45],"metastatic":[46,53],"breast":[47],"cancer":[48],"who":[49,102],"received":[50,104,160,304],"T-DM1":[51,360],"setting":[54],"between":[55],"March":[56],"2020":[57],"August":[59],"2023":[60],"Peking":[62],"University":[63],"Cancer":[64],"Hospital":[65],"five":[67],"other":[68],"medical":[69],"centers.":[70],"The":[71,119,127,189,202],"primary":[72],"endpoint":[73],"progression":[75],"free":[76],"survival":[77,84],"(PFS),":[78],"secondary":[80],"endpoints":[81],"included":[82,112],"overall":[83],"(OS),":[85],"objective":[86],"response":[87],"rate":[88,92],"(ORR),":[89],"disease":[90,175],"control":[91],"(DCR)":[93],"safety.":[95],"Results:":[96],"A":[97],"total":[98],"172":[100,181],"had":[103,158,311],"at":[105,285],"least":[106,286],"two":[107],"cycles":[108],"treatment":[110,131,242],"efficacy":[115],"safety":[117],"analysis.":[118],"median":[120,128,167,190,315],"age":[121],"53":[123],"years":[124],"(range,":[125],"24\u201387years).":[126],"number":[129],"lines":[132,243],"three(range:1-12).":[134],"47(27.3%)":[135],"first":[140],"or":[141,264],"second":[142],"line":[143],"125(72.7%)":[145],"third-":[150],"above":[152],"line.":[153],"79%":[154],"61%":[156],"pyrotinib/lapatinib":[161],"pertuzumab,":[163],"respectively.":[164],"With":[165],"a":[166,364],"follow-up":[168],"7.8":[170],"months":[171,194],"(range:":[172],"1.3-42.2),":[173],"progressive":[174],"(PD)":[176],"occurred":[177],"103":[179],"(59.9%),":[183],"26":[185],"deaths":[186],"(15.1%)":[187],"occurred.":[188],"PFS":[191,231,316,342],"5.1":[193],"(95%":[195],"CI:":[196],"3.9-6.3m).":[197],"OS":[198],"not":[200,252,339,354],"reached.":[201],"ORR":[203],"17.4%,":[205],"DCR":[207],"80.2%.":[209],"Cox":[210],"regression":[211],"analysis":[212,331],"showed":[213],"that":[214,333],"brain":[215,312],"metastasis,":[216,239,313],"lung":[217,351],"metastasis":[218,352],"HER2":[220,348],"2+":[221,349],"IHC":[223],"associated":[225],"shorter":[227],"PFS.":[228],"And":[229],"previous":[235,334],"pertuzumab":[236,305,337],"treatment,":[237],"liver":[238,276],"more":[241,298,308],"tended":[244],"to":[245],"be":[246,355],"shorter,":[247],"but":[248],"difference":[250],"statistically":[253],"significant.":[254],"Most":[255],"AEs":[256],"grade":[258,262],"1\u20132":[259],"manageable,":[261],"3":[263],"higher":[265],"adverse":[266],"events":[267],"mainly":[269],"thrombocytopenia(26":[270],"[15.1%])":[272],"elevation":[274],"enzymes":[277],"(7":[278],"[4.1%]).":[280],"36":[281],"(20.9%)":[283],"experienced":[284],"one":[287],"dose":[288,377],"reduction.":[289],"Conclusions:":[290],"this":[292],"real":[293],"world":[294],"which":[297],"than":[299,309],"half":[300],"previously,":[306],"20%":[310],"shortened":[318],"as":[319],"compared":[320],"trial":[324,327],"THERESA":[326],"results.":[328],"However,":[329],"multivariate":[330],"suggested":[332],"exposure":[335],"did":[338],"affect":[340],"T-DM1,":[344,368],"may":[353],"advantageous":[357],"population":[358],"for":[359],"treatment.":[361],"Thrombocytopenia":[362],"dose-limiting":[365],"toxicity":[366],"most":[370],"could":[372],"tolerate":[373],"it":[374],"well":[375],"after":[376],"adjustment.":[378]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2024-10-05T00:00:00"}